Self-Monitoring Platform for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a self-monitoring platform to help cancer patients track medication safety and concerns at home. It targets individuals with lung, colorectal, breast, or prostate cancer who manage their own cancer medications. The platform enables patients to report any issues or symptoms they experience, aiming to improve their health care and medication management. Participants need access to a smartphone, tablet, or computer to use the platform. As an unphased trial, this study allows patients to actively participate in enhancing their medication management and overall health care experience.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. It focuses on self-monitoring while you continue your prescribed cancer treatments.
What prior data suggests that this self-monitoring platform is safe for patients with cancer?
Research has shown that self-monitoring platforms are safe for patients. Studies have found that these platforms help track symptoms and manage side effects without causing harm. In one study, a mobile program allowed cancer patients to report symptoms and receive remote assistance without introducing new safety issues. Another study demonstrated that self-monitoring tools led to fewer hospital visits and readmissions, indicating good tolerance.
Overall, these platforms help patients manage their health without adding new risks. They encourage greater patient involvement in care, which can enhance overall experience and outcomes.12345Why are researchers excited about this trial?
Researchers are excited about the self-monitoring platform for cancer because it empowers patients to track their medication-related safety events and issues from home. Unlike traditional cancer care, which often relies heavily on in-person monitoring and appointments, this platform offers a more proactive, patient-centered approach. By providing educational materials, resources, and the option for follow-up contact with a nurse practitioner, it enables patients to have more control over their care and potentially improve their quality of life. This innovative approach aims to streamline the management of cancer treatment side effects through technology, making it a promising addition to existing care strategies.
What evidence suggests that this self-monitoring platform is effective for cancer patients?
Research has shown that self-monitoring tools can improve the quality of life for cancer patients. In one study, lung cancer patients who tracked their symptoms electronically reported feeling healthier. Another study found that self-monitoring and sharing this information reduced hospital visits, allowing cancer patients to manage their treatment more effectively at home. Additionally, smartphone apps have successfully helped patients, especially those with prostate cancer, track symptoms and manage their care. Overall, these tools help patients maintain their treatment and communicate better with healthcare providers. In this trial, participants will use a self-monitoring platform to track medication-related safety events and issues at home for six months, potentially receiving educational materials and follow-up contact from a nurse practitioner.23456
Who Is on the Research Team?
Yun Jiang
Principal Investigator
University of Michigan Rogel Cancer Center
Yang Gong
Principal Investigator
UTHealth Houston McWilliam School of Biomedical Informatics
Are You a Good Fit for This Trial?
This trial is for patients with lung, colorectal, breast, or prostate cancer who are managing their treatment at home. Participants should be taking oral anticancer medications and willing to use an online platform to track medication safety and concerns.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the self-monitoring platform to track medication-related safety events and issues at home
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants are encouraged to continue using the platform for an additional 6 months after the study period
What Are the Treatments Tested in This Trial?
Interventions
- Self-Monitoring Platform
Trial Overview
The study tests a self-monitoring online platform designed for cancer patients on oral treatments. It aims to help them report medication events and manage side effects more effectively by becoming active partners in their own care.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients use the self-monitoring platform to track medication-related safety events and issues at home for 6 months. Patients may receive relevant educational materials and resources via the platform or by email and/or receive follow-up contact from a nurse practitioner as needed over the 6 months. Patients are encouraged to continue using the platform for an additional 6 months after the study period, as desired.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Citations
Effectiveness of self-reported management program ...
Conclusions. A mobile self-reported management program has a positive effect on the quality of life of cancer patients undergoing chemotherapy. ...
Effectiveness of symptom monitoring on electronic patient ...
The meta-analysis showed significant improvement in health-related quality of life (SMD = 2.44, P < 0.001) among patients with lung cancer.
Smartphone-Based Passive Sensing in Monitoring Patients ...
SBPS was used as a monitoring tool, with passively sensed data being correlated with adverse events, symptom burden, cancer-related fatigue, decision conflict, ...
Feasibility of Wave Health to monitor electronic patient ...
In conclusion, this study demonstrates that the Wave Health app is a feasible option for collecting ePRO data in prostate cancer patients, with high compliance, ...
5.
targetedonc.com
targetedonc.com/view/how-self-monitoring-and-data-sharing-produce-better-patient-outcomesHow Self-Monitoring and Data Sharing Produce Better ...
Self-monitoring and data sharing also result in significant reductions in hospitalization and hospital readmissions, reducing the burden on ...
A Self-Monitoring Platform for Tracking Medication Safety ...
This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.